0
USD
EUR USD GBP
+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "POC Molecular Diagnostics"

Following a topic allows Research and Markets to customize your experience and provide personalized recommendations.
From
EUR$6,000USDGBP
From
EUR$4,250USDGBP
United States Molecular Point-of-Care Testing Growth Opportunities - Product Thumbnail Image

United States Molecular Point-of-Care Testing Growth Opportunities

  • Report
  • July 2022
  • 45 Pages
  • United States
From
EUR$4,950USDGBP
From
EUR$3,500USDGBP
From
EUR$4,750USDGBP
From
EUR$4,750USDGBP
From
EUR$4,750USDGBP
From
EUR$4,450USDGBP
Point-of-Care Genetic Testing Market - Forecasts from 2023 to 2028 - Product Thumbnail Image

Point-of-Care Genetic Testing Market - Forecasts from 2023 to 2028

  • Report
  • December 2023
  • 140 Pages
  • Global
From
EUR$4,450USDGBP
Loading Indicator

Point-of-Care (POC) Molecular Diagnostics is a rapidly growing field of medical diagnostics that enables the detection of genetic material from a patient sample at the point of care. This technology is used to detect and diagnose a wide range of diseases, including infectious diseases, cancer, and genetic disorders. POC Molecular Diagnostics offers a number of advantages over traditional laboratory-based testing, including faster turnaround times, improved accuracy, and cost savings. POC Molecular Diagnostics is used in a variety of settings, including hospitals, clinics, and laboratories. It is also increasingly being used in home settings, allowing patients to self-test for a variety of conditions. This technology is also being used in the field of public health, allowing for rapid detection and response to outbreaks of infectious diseases. Some companies in the POC Molecular Diagnostics market include Cepheid, Hologic, Abbott, and Roche. Show Less Read more

This website uses cookies to ensure you get the best experience. Learn more